Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05058976 · ClinicalTrials.gov registry record · Phase 4
Romosozumab Use to Build Skeletal Integrity
A Phase 4 study of Osteoporosis and Osteoporosis, Postmenopausal, sponsored by Susan L. Greenspan.
- Active
- Registry status
- Phase 4
- Development phase
- 184
- Enrollment target
- 1
- Study location
NCT05058976 is a Phase 4 study of Osteoporosis and Osteoporosis, Postmenopausal that is active but no longer recruiting, run by Susan L. Greenspan. The registered enrollment target is 184 participants, below the 1,544-participant average among 84 other Osteoporosis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05058976, a Phase 4 study of Osteoporosis and Osteoporosis, Postmenopausal, is active but no longer recruiting, sponsored by Susan L. Greenspan.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 184 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out if one year of romosozumab (Evenity®), a monthly injection given in the arm under the skin, prior to an infusion of zoledronic acid Reclast®, works to treat bone loss and prevent it from worsening in older women (ages 65 and older) who have osteoporosis and reside in long-term care (LTC) facilities.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Romosozumab
- DRUG Zoledronic acid
- DIETARY_SUPPLEMENT Calcium and Vitamin D
Study Locations (1)
Pennsylvania
- UPMC Senior Communities - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2027-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05058976
The ClinicalTrials.gov registry entry for NCT05058976 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,544-participant average among 84 other Osteoporosis trials with a reported enrollment target (88% lower). The listed sponsor is Susan L. Greenspan, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Osteoporosis appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT05058976 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05058976 about?
NCT05058976 is a clinical study titled "Romosozumab Use to Build Skeletal Integrity". The purpose of this study is to find out if one year of romosozumab (Evenity®), a monthly injection given in the arm under the skin, prior to an infusion of zoledronic acid Reclast®, works to treat bone loss and prevent it from worsening in older women (ages 65 and older) who have osteoporosis and r...
What is the current status of trial NCT05058976?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 184 participants. The study started on 2021-09-15. Estimated completion is 2027-03-31.
What conditions does trial NCT05058976 study?
This clinical trial studies the following conditions: Osteoporosis, Osteoporosis, Postmenopausal, Osteoporosis Fracture.
What interventions are being tested in trial NCT05058976?
The interventions under investigation include: Placebo (DRUG), Romosozumab (DRUG), Zoledronic acid (DRUG), Calcium and Vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05058976?
This trial is sponsored by Susan L. Greenspan, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05058976 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preserving Geriatric Muscle With an Osteoporosis Medication
RECRUITING · Phase 4
-
Combined Anabolic Therapy
RECRUITING · Phase 4
-
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
ACTIVE NOT RECRUITING · Phase 4
-
Denosumab (DMAB) Discontinuation and Switching in Glucocorticoid-Induced Osteoporosis (GIOP): a Pilot Study
ACTIVE NOT RECRUITING · Phase 4
-
Comparative Antiresorptive Efficacy Discontinuation of Denosumab
ACTIVE NOT RECRUITING · Phase 4
-
Trial of Parkinson's And Zoledronic Acid
ACTIVE NOT RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.